M. Beljanski

The anticancer agent PB-100, selectively active on malignant cells, inhibits multiplication of sixteen malignant cell lines, even multidrug resistant

M. Beljanski, 2000 .

Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture.

M. Stroun, P. Maurice, C. Lederrey, 1978, Cancer research.

Selective inhibition of in vitro synthesis of cancer DNA by alkaloids of beta-carboline class.

M. Beljanski, 1982, Experimental cell biology.

Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs.

M. Beljanski, 1986, Oncology.

Neoplastic characteristics of the DNA found in the plasma of cancer patients.

M. Stroun, P. Maurice, J. Lyautey, 1989, Oncology.

The selective anticancer agents PB-100 and BG-8 are active against human melanoma cells, but do not affect non malignant fibroblasts.

S. Crochet, M. Beljanski, 1996, International journal of oncology.